Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart

Journal of Heart and Lung Transplantation

Volumn 29, Issue 5, 2010, Pages 554-561

  Ogletree, Monique L ^a   Sweet, Wendy E ^a   Talerico, Cassandra ^a   Klecka, Mary E ^a   Young, James B ^a   Smedira, Nicholas G ^a   Starling, Randall C ^a   Moravec, Christine S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Ca2+; contractility; heart failure; heart assist device; sarcoendoplasmic reticulum Ca2+ ATPase

Indexed keywords

CALSEQUESTRIN; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADULT; AGED; ARTICLE; CALCIUM HANDLING; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENDOPLASMIC RETICULUM; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; TREATMENT OUTCOME;

ADULT; AGED; CALCIUM; CALCIUM-BINDING PROTEINS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VENTRICULAR FUNCTION, LEFT;

EID: 77950517612     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.10.015     Document Type: Article

References (46)

1. Gwathmey J.K., Copelas L., Mackinnon R., et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61 (1987) 70-76
2. Hasenfuss G., Mulieri L.A., Leavitt B.J., et al. Alterations of contractile function and excitation contraction coupling in dilated cardiomyopathy. Circ Res 70 (1992) 1225-1232
3. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307 (1982) 205-211
4. 2+ handling. J Clin Invest 98 (1996) 764-776
5. Burkhoff D., Klotz S., and Mancini D.M. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail 12 (2006) 227-239
6. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62 (1996) 675-682
7. Maybaum S., Mancini D., Xydas S., et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115 (2007) 2497-2505
8. James K.B., McCarthy P.M., Thomas J.D., et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92 (1995) II-191-5
9. Goldstein D.J., Moazami N., Seldomridge J.A., et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 63 (1997) 971-974
10. Zafeiridis A., Jeevanandam V., Houser S.R., et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
11. McCarthy P.M., Nakatani S., Vargo R., et al. Structural and left ventricular histological changes after implantable LVAD insertion. Ann Thorac Surg 59 (1995) 609-613
12. Aquila L.A., McCarthy P.M., Smedira N.G., et al. Cytoskeletal structure and recovery in single human cardiac myocytes. J Heart Lung Transplant 23 (2004) 954-963
13. Altemose G.T., Gritsus V., Jeevanandam V., et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 16 (1997) 765-773
14. Xydas S., Rosen R.S., Ng C., et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 25 (2006) 7-15
15. Lowes B.D., Zolty R., Shakar S.F., et al. Assist devices fail to reverse patterns of fetal gene expression despite β-blockers. J Heart Lung Transplant 26 (2007) 1170-1176
16. Dipla K., Mattiello J.A., Jeevanandam V., et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97 (1998) 2316-2322
17. Ogletree-Hughes M.L., Stull L.B., et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
18. Muller J., Wallukat G., Weng Y.-G., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
19. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
20. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
21. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
22. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
23. Dandel M., Weng Y., Siniawski H., et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 118 suppl 1 (2008) S94-S105
24. Mano A., Naktatani T., Oda N., et al. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system?. J Heart Lung Transplant 27 (2008) 869-874
25. Latif N., Yacoub M.H., George R., et al. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant 26 (2007) 230-235
26. Gwathmey J.K., Slawsky M.T., Hajjar R.J., et al. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85 (1990) 1599-1613
27. Pieske B., Kretschmann B., Meyer M., et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 92 (1995) 1169-1178
28. Hajjar R.J., Zsebo K., Deckelbaum L., et al. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail 14 (2008) 355-367
29. Heerdt P.M., Holmes J.W., Cai B., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102 (2000) 2713-2719
30. Rodrigue-Way A., Burkoff D., Geesaman B.J., et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant 24 (2005) 73-80
31. Barbone A., Holmes J.W., Heerdt P.M., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure. A primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
32. 2+ cycling after left ventricular device support in the failing human heart. J Am Coll Cardiol 44 (2004) 837-845
33. Madigan J.D., Barbone A., Choudhri A.F., et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121 (2001) 902-908
34. Moravec C.S., Schluchter M.D., Paranandi L., et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation 82 (1990) 1973-1984
35. DiPaola N.R., Sweet W.E., Stull L.B., et al. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied, and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol 33 (2001) 1283-1295
36. Koss K.L., Grupp I.L., and Kranias E.G. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Bas Res Cardiol 92 (1997) 17-24
37. Mulieri L.A., Hasenfuss G., Leavitt B., et al. Altered myocardial force-frequency relation in human heart failure. Circulation 85 (1992) 1743-1750
38. Hasenfuss G., Reinecke H., Studer R., et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and non-failing human myocardium. Circ Res 75 (1994) 434-442
39. Davies C.H., Davia K., Bennett J.G., et al. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92 (1995) 2540-2549
40. Westaby S., Jin X.Y., Katsumata T., et al. Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery. Ann Thorac Surg 64 (1997) 1301-1308
41. 2+ cycling proteins and Gαq signaling after left ventricular device support in failing human hearts. Cardiovasc Res 45 (2000) 883-888
42. Butter C., Rastogi S., Minden H.H., et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 51 (2008) 1784-1789
43. Vanderheyden M., Mullens W., del Rue L., et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51 (2008) 129-136
44. 2+ exchanger in failing human myocardium. Circulation 94 (1996) 992-1002
45. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
46. Maybaum S., Epstein S., Beniaminovitz A., et al. Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism, and increased exercise capacity. J Heart Lung Transplant 21 (2002) 446-454